This is a table of type proper and their frequencies. Use it to search & browse the list to learn more about your study carrel.
proper | frequency |
---|---|
IgE | 1107 |
der | 939 |
COPD | 800 |
Asthma | 656 |
RSV | 577 |
von | 540 |
T | 446 |
mg | 428 |
und | 396 |
mit | 320 |
PCR | 316 |
eine | 311 |
ICS | 302 |
C | 299 |
da | 287 |
IL-5 | 276 |
FEV1 | 267 |
bei | 265 |
A | 254 |
FEV | 254 |
zu | 246 |
Health | 246 |
das | 239 |
HRV | 235 |
auch | 227 |
IFN | 226 |
AR | 224 |
IL-6 | 222 |
L | 217 |
RV | 207 |
den | 205 |
United | 199 |
werden | 197 |
CI | 195 |
B | 192 |
einer | 186 |
M | 181 |
IgA | 180 |
auf | 179 |
IL-4 | 175 |
ECP | 173 |
Study | 163 |
ELISA | 162 |
States | 158 |
CD4 | 157 |
OCS | 154 |
CT | 153 |
National | 151 |
asma | 150 |
na | 149 |
Hospital | 147 |
CF | 144 |
sich | 142 |
Group | 142 |
EA | 142 |
wird | 139 |
durch | 137 |
COVID-19 | 137 |
AHR | 135 |
des | 134 |
IL-8 | 134 |
ist | 133 |
IL-13 | 133 |
Australia | 133 |
IV | 132 |
airways | 130 |
OSA | 129 |
RNA | 128 |
| | 128 |
II | 126 |
Allergy | 125 |
sind | 124 |
dass | 124 |
airway | 123 |
uma | 120 |
Th | 120 |
TNF | 120 |
Der | 120 |
• | 118 |
nach | 118 |
University | 117 |
Methods | 117 |
CRS | 117 |
TGF | 115 |
SBS | 115 |
IL-10 | 114 |
nicht | 114 |
os | 113 |
Ϯ | 112 |
Background | 112 |
SLIT | 111 |
J | 111 |
budesonide | 109 |
Table | 107 |
TSLP | 107 |
PEF | 107 |
Fig | 106 |
para | 105 |
AIT | 105 |
zur | 104 |
Department | 103 |
D | 103 |
oder | 103 |
über | 103 |
SPT | 102 |
asthma | 101 |
IgG | 100 |
mL | 99 |
Rhinovirus | 98 |
Lung | 98 |
Association | 98 |
S. | 97 |
als | 95 |
Respiratory | 95 |
HDM | 95 |
kann | 94 |
FENO | 93 |
BAL | 93 |
E | 92 |
B. | 91 |
þ | 90 |
hyperresponsiveness | 90 |
Research | 90 |
em | 89 |
HIV | 88 |
S | 87 |
Human | 87 |
Ara | 87 |
HAE | 86 |
TB | 85 |
HES | 85 |
aus | 83 |
CD8 | 83 |
L. | 82 |
GM | 82 |
Society | 82 |
CSF | 79 |
SCIT | 79 |
RT | 78 |
ED | 78 |
ASM | 78 |
kU | 77 |
mRNA | 76 |
Medical | 76 |
dem | 75 |
US | 75 |
ISAAC | 75 |
Disease | 75 |
ein | 74 |
Erkrankungen | 74 |
Prevention | 73 |
CPAP | 72 |
Eosinophils | 72 |
sowie | 72 |
OVA | 71 |
GINA | 71 |
FVC | 71 |
sera | 70 |
Medicine | 70 |
SARS | 69 |
Th2 | 69 |
anti | 69 |
dos | 68 |
TLR | 68 |
Institute | 68 |
IU | 68 |
F | 68 |
C. | 68 |
China | 67 |
HBoV | 67 |
PGE2 | 67 |
μg | 66 |
New | 66 |
LABA | 66 |
III | 66 |
± | 65 |
parainfluenza | 65 |
aber | 65 |
MC | 65 |
Chronic | 65 |
BMI | 65 |
einem | 64 |
Control | 64 |
Bei | 64 |
Europe | 63 |
omalizumab | 63 |
IPF | 63 |
mite | 62 |
bronchoalveolar | 62 |
montelukast | 61 |
meta | 61 |
Patient | 61 |
LPS | 61 |
Chlamydia | 61 |
com | 60 |
P. | 60 |
HRCT | 60 |
GORD | 60 |
< | 60 |
Children | 59 |
GWAS | 59 |
Alternaria | 59 |
NHMRC | 59 |
kg | 59 |
M. | 59 |
prednisone | 59 |
z. | 59 |
resposta | 58 |
können | 58 |
Zellen | 58 |
G | 58 |
Global | 57 |
Germany | 57 |
GERD | 57 |
Childhood | 57 |
CD14 | 57 |
BPD | 57 |
A. | 57 |
não | 56 |
como | 56 |
wie | 56 |
▬ | 56 |
für | 55 |
MBP | 55 |
K | 55 |
Japan | 55 |
I | 55 |
EBC | 55 |
tezepelumab | 54 |
nos | 54 |
bzw | 54 |
UK | 54 |
American | 54 |
EPA | 53 |
DOI | 53 |
LTP | 53 |
Spain | 53 |
sha | 53 |
vor | 52 |
SNPs | 52 |
SNP | 52 |
SD | 52 |
NK | 52 |
FeNO | 52 |
Clinical | 52 |
Care | 51 |
ILD | 51 |
CIC | 51 |
H3cit | 51 |
International | 51 |
Phase | 51 |
Survey | 51 |
azithromycin | 51 |
monocyte | 50 |
Thoracic | 50 |
September | 50 |
CRP | 50 |
CD34 | 50 |
mm | 49 |
Wirkung | 49 |
SN | 49 |
Report | 49 |
PE | 49 |
IVIG | 49 |
AHI | 49 |
ATS | 48 |
Airway | 48 |
D. | 48 |
AE | 48 |
CFTR | 48 |
ou | 48 |
OSAS | 48 |
sein | 48 |
es | 48 |
uenza | 48 |
FOT | 47 |
DC | 47 |
DNA | 47 |
EDN | 47 |
LT | 47 |
ICU | 47 |
IL-33 | 47 |
Italy | 47 |
IL-17 | 47 |
metapneumovirus | 46 |
USA | 46 |
ECM | 46 |
ECG | 46 |
CD3 | 46 |
Rhinitis | 45 |
NSW | 45 |
E. | 45 |
SDS | 45 |
U.S. | 45 |
fl | 45 |
mais | 44 |
einen | 44 |
allergischen | 44 |
Initiative | 44 |
H | 44 |
Aktivierung | 43 |
Effect | 43 |
European | 43 |
Foundation | 43 |
July | 43 |
Management | 43 |
NF | 43 |
Omalizumab | 43 |
Patienten | 43 |
QOL | 43 |
beim | 43 |
Questionnaire | 43 |
pH | 43 |
diese | 43 |
Rahmen | 43 |
U | 43 |
SE | 43 |
Review | 43 |
A4 | 42 |
Center | 42 |
CoV-2 | 42 |
EGID | 42 |
ETS | 42 |
Guidelines | 42 |
June | 42 |
Kingdom | 42 |
MS | 42 |
PM | 42 |
SEM | 42 |
World | 42 |
house | 42 |
obstruktiven | 42 |
é | 42 |
α | 42 |
ST | 42 |
Cochrane | 41 |
ACT | 41 |
AUC | 41 |
IL-2 | 41 |
Entzündung | 41 |
vivo | 41 |
Spirometry | 41 |
serum | 40 |
die | 40 |
ROC | 40 |
RANTES | 40 |
Pru | 40 |
Makrophagen | 40 |
MR | 40 |
Influenza | 40 |
Ars | 40 |
jedoch | 40 |
Eine | 39 |
Bet | 39 |
DES | 39 |
MAPK | 39 |
IgM | 39 |
MDI | 39 |
haben | 39 |
PCN | 38 |
AM | 38 |
ER | 38 |
ERS | 38 |
FRC | 38 |
Hong | 38 |
Montelukast | 38 |
PCD | 38 |
Infecção | 38 |
SABA | 38 |
fexofenadine | 38 |
SIRT1 | 38 |
por | 38 |
ml | 38 |
Mendes | 38 |
basophil | 38 |
Singapore | 38 |
Syndrome | 38 |
Phl | 37 |
BALF | 37 |
IL | 37 |
Immunology | 37 |
Infektion | 37 |
Kong | 37 |
OIT | 37 |
MBL | 37 |
Pulmonary | 37 |
Results | 37 |
Test | 37 |
eotaxin | 37 |
ng | 37 |
sie | 37 |
zwischen | 37 |
Pinto | 37 |
HFD | 36 |
ABPA | 36 |
ARI | 36 |
CMA | 36 |
CVID | 36 |
City | 36 |
DCs | 36 |
DHA | 36 |
HCU | 36 |
Leukotriene | 36 |
Treatment | 36 |
atopia | 36 |
cysteinyl | 36 |
nur | 36 |
ser | 36 |
vírus | 36 |
β | 36 |
OAS | 36 |
Dermatophagoides | 35 |
Allergen | 35 |
America | 35 |
Atemwege | 35 |
CO | 35 |
Committee | 35 |
Organization | 35 |
Introduction | 35 |
Martinez | 35 |
PM10 | 35 |
fi | 35 |
pg | 35 |
Studie | 34 |
MRI | 34 |
PR-10 | 34 |
SP | 34 |
NPA | 34 |
Studien | 34 |
rhinoconjunctivitis | 34 |
exposição | 34 |
allergischer | 34 |
IL-1 | 33 |
Bedeutung | 33 |
Behandlung | 33 |
C1-INH | 33 |
CC | 33 |
Eo | 33 |
FP | 33 |
Hemmung | 33 |
H1N1 | 33 |
IL-12 | 33 |
J. | 33 |
N | 33 |
PTX | 33 |
Rolle | 33 |
South | 33 |
loratadine | 33 |
wurde | 33 |
IOS | 33 |
France | 32 |
Lipidmediatoren | 32 |
Kindern | 32 |
H2O2 | 32 |
Abb | 32 |
December | 32 |
D1 | 32 |
PAI-2 | 32 |
Melbourne | 32 |
Community | 32 |
PVOD | 32 |
Typ | 32 |
bis | 32 |
células | 32 |
endotoxinas | 32 |
estudos | 32 |
infecções | 32 |
mepolizumab | 32 |
zum | 32 |
Pediatric | 32 |
RAST | 31 |
Asia | 31 |
BALB | 31 |
GP | 31 |
MMP-9 | 31 |
P | 31 |
VAS | 31 |
Sweden | 31 |
bronchiolitis | 31 |
nan | 31 |
noch | 31 |
sehr | 31 |
January | 30 |
ACQ | 30 |
Anti | 30 |
Bronchiolitis | 30 |
CBT | 30 |
CD25 | 30 |
E2 | 30 |
neutrophilic | 30 |
Lipoxine | 30 |
North | 30 |
ROS | 30 |
Unit | 30 |
vida | 30 |
Mas | 30 |
CVD | 29 |
ICAM-1 | 29 |
GI | 29 |
Diese | 29 |
Canada | 29 |
AA | 29 |
CPI | 29 |
COX-2 | 29 |
8) | 29 |
Jahren | 29 |
IL13 | 29 |
signifi | 29 |
Lipoxin | 29 |
Therapie | 29 |
NC | 29 |
range | 29 |
formoterol | 29 |
γ | 29 |
TLC | 29 |
TBB | 29 |
Sydney | 29 |
SAR | 29 |
CTPA | 28 |
HC | 28 |
Fisher | 28 |
Fel | 28 |
England | 28 |
EPO | 28 |
EAACI | 28 |
CpG | 28 |
Azithromycin | 28 |
CP | 28 |
CAP | 28 |
CAM | 28 |
Bosentan | 28 |
AQOL | 28 |
ADHD | 28 |
Korea | 28 |
HLA | 28 |
ImmunoCAP | 28 |
nas | 28 |
TH2 | 28 |
risco | 28 |
LAR | 28 |
bereits | 28 |
aumento | 28 |
ao | 28 |
W | 28 |
Treg | 28 |
VSR | 28 |
Sacin | 28 |
SDB | 28 |
R | 28 |
Penicillium | 28 |
PI-9 | 28 |
PAGE | 28 |
P<.001 | 28 |
Conclusion | 27 |
AQI | 27 |
Abschn | 27 |
Balb | 27 |
CU | 27 |
May | 27 |
Infektionen | 27 |
MD | 27 |
October | 27 |
Royal | 27 |
Toll | 27 |
ID | 26 |
EE | 26 |
GPs | 26 |
Eosinophilen | 26 |
East | 26 |
Australian | 26 |
CD | 26 |
C1 | 26 |
Atopic | 26 |
AERD | 26 |
ISAC | 26 |
IL-3 | 26 |
FA | 26 |
Immunol | 26 |
atópica | 26 |
schweren | 26 |
já | 26 |
spirometry | 26 |
eines | 26 |
control | 26 |
Mycoplasma | 26 |
WT | 26 |
während | 26 |
R. | 26 |
Quality | 26 |
SPSS | 26 |
CIU | 25 |
Entwicklung | 25 |
ETs | 25 |
EMT | 25 |
EGFR | 25 |
Clin | 25 |
CD19 | 25 |
CFU | 25 |
CCL11 | 25 |
C4 | 25 |
BL | 25 |
Evaluation | 25 |
A1AT | 25 |
Impact | 25 |
IL-17A | 25 |
akuten | 25 |
methotrexate | 25 |
NOx | 25 |
hRV | 25 |
dieser | 25 |
besonders | 25 |
infl | 25 |
VKC | 25 |
URI | 25 |
TNFa | 25 |
Port | 25 |
PH | 25 |
MUC5AC | 24 |
General | 24 |
London | 24 |
Life | 24 |
LPR | 24 |
Index | 24 |
IgG1 | 24 |
IC | 24 |
Hedland | 24 |
HP | 24 |
Asthmatikern | 24 |
FDA | 24 |
Efficacy | 24 |
Effekt | 24 |
COX | 24 |
CCL5 | 24 |
Bildung | 24 |
BIA | 24 |
Auch | 24 |
ANOVA | 24 |
NCPAP | 24 |
Mexico | 24 |
Coronavirus | 24 |
NP | 24 |
West | 24 |
P<.05 | 24 |
primeiros | 24 |
s. | 24 |
pode | 24 |
imune | 24 |
führen | 24 |
deren | 24 |
virusal | 24 |
association | 24 |
aeroallergens | 24 |
mas | 24 |
VTE | 24 |
Rezeptoren | 24 |
VLCD | 24 |
PA | 24 |
PK | 24 |
Program | 24 |
Scond | 24 |
Staphylococcus | 24 |
TBW | 24 |
VEGF | 24 |
Lymphozyten | 23 |
Formen | 23 |
LTC | 23 |
Kinder | 23 |
IL-11 | 23 |
Heart | 23 |
G. | 23 |
CDC | 23 |
FSC | 23 |
FD | 23 |
Diseases | 23 |
Case | 23 |
CA | 23 |
Beijing | 23 |
MMP-2 | 23 |
M2 | 23 |
Neutrophilen | 23 |
March | 23 |
amoxicillin | 23 |
κB | 23 |
Method | 23 |
verschiedene | 23 |
specific | 23 |
lavage | 23 |
defi | 23 |
bocavirus | 23 |
Virus | 23 |
Sleep | 23 |
Severe | 23 |
Peak | 23 |
PBS | 23 |
NY | 23 |
Das | 22 |
H. | 22 |
February | 22 |
Erkrankung | 22 |
Diagnostik | 22 |
Development | 22 |
Allergic | 22 |
DVT | 22 |
CTA | 22 |
Brazil | 22 |
Blood | 22 |
BD | 22 |
Analysis | 22 |
NAC | 22 |
HCoV | 22 |
Support | 22 |
Netherlands | 22 |
benefi | 22 |
Neutrophil | 22 |
são | 22 |
quando | 22 |
pteronyssinus | 22 |
muss | 22 |
interleukin-5 | 22 |
pela | 22 |
andere | 22 |
Viral | 22 |
Tumstatin | 22 |
TLR4 | 22 |
System | 22 |
PFT | 22 |
Council | 21 |
LRTI | 21 |
India | 21 |
Ig | 21 |
Gruppe | 21 |
FEX | 21 |
EoE | 21 |
Emergency | 21 |
ANA | 21 |
CXCL8 | 21 |
BP | 21 |
BA | 21 |
Assessment | 21 |
Aspirin | 21 |
Airways | 21 |
MM | 21 |
ACE2 | 21 |
16S | 21 |
MHC | 21 |
PAF | 21 |
November | 21 |
granzyme | 21 |
wenn | 21 |
sollte | 21 |
qPCR | 21 |
Ole | 21 |
p1 | 21 |
mittels | 21 |
kB | 21 |
papel | 21 |
deutlich | 21 |
T. | 21 |
Sensibilisierung | 21 |
Reaktion | 21 |
Protein | 21 |
Patients | 21 |
PAH | 21 |
TLR7 | 21 |
Exacerbations | 20 |
IQR | 20 |
Journal | 20 |
LC | 20 |
Nutrition | 20 |
LX | 20 |
NSAID | 20 |
Nach | 20 |
OAD | 20 |
FFMI | 20 |
BMS | 20 |
Eosinophilia | 20 |
Data | 20 |
CSU | 20 |
Bronchitis | 20 |
BRS | 20 |
BMP | 20 |
Arachidonsäure | 20 |
Alt | 20 |
ABSTRACTS | 20 |
Pathogenese | 20 |
PBMC | 20 |
IP-10 | 20 |
RQLQ | 20 |
ersten | 20 |
SS | 20 |
® | 20 |
sensibilização | 20 |
outros | 20 |
nomeadamente | 20 |
lipoxin | 20 |
indem | 20 |
hMPV | 20 |
gpx-1 | 20 |
miRNA | 20 |
dust | 20 |
às | 20 |
aufgrund | 20 |
atopic | 20 |
anos | 20 |
anderen | 20 |
alternata | 20 |
agressão | 20 |
Vergleich | 20 |
des[Arg | 20 |
GC | 19 |
JC | 19 |
ILC2 | 19 |
IL-1β | 19 |
I. | 19 |
Atemwegserkrankungen | 19 |
Force | 19 |
Chi | 19 |
CCR3 | 19 |
BV | 19 |
NIH | 19 |
MP | 19 |
MCC | 19 |
Prävalenz | 19 |
Tucson | 19 |
Scientific | 19 |
total | 19 |
hypereosinophilic | 19 |
dadurch | 19 |
VCAM-1 | 19 |
ohne | 19 |
Th17 | 19 |
TNSS | 19 |
TIMP-1 | 19 |
Somit | 19 |
TOF | 19 |
NO | 18 |
Esta | 18 |
Food | 18 |
Gabe | 18 |
Granulozyten | 18 |
M3 | 18 |
IL-25 | 18 |
Immune | 18 |
Mann | 18 |
Mepolizumab | 18 |
Education | 18 |
Entzündungsauflösung | 18 |
Atopy | 18 |
ECRHS | 18 |
CTL | 18 |
CGD | 18 |
Budesonide | 18 |
Bronchitiden | 18 |
British | 18 |
April | 18 |
Allergies | 18 |
AOM | 18 |
AEs | 18 |
-5 | 18 |
PMA | 18 |
OR | 18 |
Whitney | 18 |
PS | 18 |
brônquica | 18 |
Prick | 18 |
zeigen | 18 |
weniger | 18 |
verschiedenen | 18 |
sIgE | 18 |
resultados | 18 |
nonatopic | 18 |
klinische | 18 |
führt | 18 |
ed | 18 |
ebenfalls | 18 |
menos | 18 |
bactérias | 18 |
TLR3 | 18 |
RDS | 18 |
astemizole | 18 |
SQ | 18 |
School | 18 |
TCM | 18 |
Reduktion | 18 |
Use | 18 |
York | 18 |
allergische | 18 |
Fibrosis | 17 |
PG | 17 |
OFC | 17 |
None | 17 |
NAEPP | 17 |
MMR | 17 |
MCP-1 | 17 |
Institutes | 17 |
Hierzu | 17 |
HMPV | 17 |
GVHD | 17 |
Function | 17 |
First | 17 |
Bronchiectasis | 17 |
FEF | 17 |
Epidemiology | 17 |
Ein | 17 |
EV | 17 |
Diagnosis | 17 |
DP | 17 |
Cypher | 17 |
Cohort | 17 |
Cladosporium | 17 |
CNS | 17 |
CD45 | 17 |
BDP | 17 |
Air | 17 |
Registry | 17 |
RCT | 17 |
OC43 | 17 |
RvD1 | 17 |
gegenüber | 17 |
SA | 17 |
wieder | 17 |
vom | 17 |
unter | 17 |
pelo | 17 |
neutrophilia | 17 |
neben | 17 |
nachgewiesen | 17 |
modulaçâo | 17 |
man | 17 |
keine | 17 |
immunoblot | 17 |
glycocalyx | 17 |
sowohl | 17 |
bronchiale | 17 |
TM | 17 |
Serum | 17 |
allem | 17 |
Sie | 17 |
Sputum | 17 |
Symptome | 17 |
Spearman | 17 |
Tab | 17 |
Th1 | 17 |
Turkey | 17 |
VC | 17 |
Y | 17 |
Zeit | 17 |
E1 | 16 |
GA | 16 |
EBV | 16 |
Equ | 16 |
Es | 16 |
FET | 16 |
FOLFOX | 16 |
Fibroblasten | 16 |
Finland | 16 |
Funktion | 16 |
Johnston | 16 |
Garcia | 16 |
ICC | 16 |
IL-9 | 16 |
IL33 | 16 |
INS | 16 |
Kap | 16 |
Konzentration | 16 |
M1 | 16 |
MA | 16 |
Dex | 16 |
Drug | 16 |
August | 16 |
D68 | 16 |
Cys | 16 |
-3 | 16 |
ACAM | 16 |
ACD | 16 |
ADF | 16 |
Academy | 16 |
Acupuncture | 16 |
Africa | 16 |
Arg16 | 16 |
MKP-1 | 16 |
B4 | 16 |
BHR | 16 |
BMPR | 16 |
BT | 16 |
Bronchoalveolar | 16 |
CD16 | 16 |
CPB | 16 |
CRC | 16 |
California | 16 |
Centre | 16 |
Cetirizine | 16 |
Clinic | 16 |
MI | 16 |
RvE1 | 16 |
MLT | 16 |
expiratory | 16 |
gebildet | 16 |
hemmt | 16 |
inflamação | 16 |
kDa | 16 |
PCL | 16 |
kommt | 16 |
konnte | 16 |
lys | 16 |
mesothelin | 16 |
mmHg | 16 |
multicentre | 16 |
populações | 16 |
prevalência | 16 |
sobre | 16 |
sondern | 16 |
spezifischen | 16 |
tetraplegia | 16 |
tryptase | 16 |
zeigt | 16 |
ß1 | 16 |
− | 16 |
farinae | 16 |
klinischen | 16 |
daher | 16 |
Task | 16 |
PI | 16 |
Practice | 16 |
Project | 16 |
crianças | 16 |
Reaktionen | 16 |
Resolvine | 16 |
SAA | 16 |
TLR2 | 16 |
TLco | 16 |
RMV | 16 |
Thermo | 16 |
Wang | 16 |
Wells | 16 |
Xrs | 16 |
Zealand | 16 |
Zrs | 16 |
aspergillosis | 16 |
asthmatischen | 16 |
control/10 | 16 |
WAP | 16 |
Mäusen | 15 |
K. | 15 |
LA | 15 |
Lebensjahr | 15 |
Mediterranean | 15 |
Monitoring | 15 |
PIV | 15 |
O | 15 |
OSDB | 15 |
PD | 15 |
PFAS | 15 |
Pacifi | 15 |
High | 15 |
IgE. | 15 |
Pharmaceutical | 15 |
HCl | 15 |
Environmental | 15 |
Entzündungen | 15 |
E4 | 15 |
DR | 15 |
DL | 15 |
Challenge | 15 |
CMV | 15 |
C2 | 15 |
BMP4 | 15 |
Aufgrund | 15 |
Aspergillus | 15 |
Allergien | 15 |
AMS | 15 |
Palivizumab | 15 |
non | 15 |
Resolvin | 15 |
dl | 15 |
Rezeptor | 15 |
spielen | 15 |
sollten | 15 |
schon | 15 |
rhinorrhea | 15 |
p<0.0001 | 15 |
wirken | 15 |
lg | 15 |
könnte | 15 |
group | 15 |
gibt | 15 |
fed | 15 |
endotypes | 15 |
reduziert | 15 |
dann | 15 |
Torres | 15 |
cromolyn | 15 |
S2 | 15 |
SCORAD | 15 |
TH17 | 15 |
Thymic | 15 |
Strauss | 15 |
VA | 15 |
VIT | 15 |
Woolcock | 15 |
Wuhan | 15 |
Während | 15 |
Form | 14 |
KU | 14 |
Frequency | 14 |
GSH | 14 |
Husten | 14 |
INF | 14 |
Inc. | 14 |
Intensive | 14 |
Interest | 14 |
MV | 14 |
Krupp | 14 |
LOA | 14 |
Lee | 14 |
Leukozyten | 14 |
MCP-3 | 14 |
Moraxella | 14 |
Network | 14 |
Exposure | 14 |
FIP1L1 | 14 |
Ab | 14 |
Examination | 14 |
BTS | 14 |
A2 | 14 |
ARDS | 14 |
ARIA | 14 |
AT | 14 |
OA | 14 |
Age | 14 |
Auflösung | 14 |
Box | 14 |
Eosinophil | 14 |
CCL19 | 14 |
CV | 14 |
Cancer | 14 |
Churg | 14 |
Corticosteroids | 14 |
Day | 14 |
Doxil | 14 |
Northern | 14 |
LCI | 14 |
OP | 14 |
erhöht | 14 |
hiperreactividade | 14 |
imunidade | 14 |
innerhalb | 14 |
interleukin-4 | 14 |
lässt | 14 |
meist | 14 |
p<0.01 | 14 |
poderão | 14 |
scheint | 14 |
sibilâncias | 14 |
specifi | 14 |
tem | 14 |
vezes | 14 |
virusais | 14 |
wichtige | 14 |
⊡ | 14 |
PDGF | 14 |
grande | 14 |
reduzieren | 14 |
dipropionate | 14 |
Taiwan | 14 |
Pediatrics | 14 |
dafür | 14 |
Prostaglandine | 14 |
Receptor | 14 |
Syncytial | 14 |
TAA | 14 |
TT | 14 |
TLRs | 14 |
Van | 14 |
WHO | 14 |
antibióticos | 14 |
azelastine | 14 |
beclomethasone | 14 |
V | 14 |
catarrhalis | 14 |
classifi | 14 |
EoE. | 13 |
Gene | 13 |
Granzyme | 13 |
Grant | 13 |
Gewebe | 13 |
FDEIA | 13 |
Gegensatz | 13 |
Faktoren | 13 |
House | 13 |
Ergebnisse | 13 |
HFA | 13 |
MACS | 13 |
Hz | 13 |
IAQ | 13 |
IRB | 13 |
Immunotherapy | 13 |
Immuntherapie | 13 |
Inflammation | 13 |
Jackson | 13 |
Mechanismen | 13 |
Menge | 13 |
EF | 13 |
ESS | 13 |
ASA | 13 |
EAA | 13 |
BID | 13 |
NGF | 13 |
-8 | 13 |
AAP | 13 |
ANCA | 13 |
AST | 13 |
Act | 13 |
Activation | 13 |
Asian | 13 |
BCX7353 | 13 |
BR | 13 |
Discussion | 13 |
Bt | 13 |
CRD | 13 |
CURB-65 | 13 |
Ch | 13 |
College | 13 |
Cystic | 13 |
DPT | 13 |
De | 13 |
Dieser | 13 |
Mutius | 13 |
QM1S | 13 |
NHANES | 13 |
UI | 13 |
Uppsala | 13 |
Western | 13 |
Workshop | 13 |
antiinflammatorischen | 13 |
bronchopulmonary | 13 |
cetirizine | 13 |
efeito | 13 |
entzündlichen | 13 |
este | 13 |
kali | 13 |
kallikrein | 13 |
medication | 13 |
mehr | 13 |
miRNAs | 13 |
n=10 | 13 |
novo | 13 |
oscillometry | 13 |
verantwortlich | 13 |
virus | 13 |
wobei | 13 |
NHIS | 13 |
Untersuchungen | 13 |
peach | 13 |
Type | 13 |
Pseudomonas | 13 |
NHLF | 13 |
TP | 13 |
NJ | 13 |
Nachdem | 13 |
OPN | 13 |
Orleans | 13 |
Para | 13 |
Portugal | 13 |
Prostaglandin | 13 |
NSCLC | 13 |
Respirology | 13 |
Risiko | 13 |
Risk | 13 |
SJS | 13 |
Safety | 13 |
TIMP-2 | 13 |
San | 13 |
T2 | 13 |
Service | 13 |
Regulation | 13 |
Flu | 12 |
ILC2-Zellen | 12 |
Huang | 12 |
IBD | 12 |
Infekten | 12 |
INH | 12 |
Immunreaktion | 12 |
Infection | 12 |
Helicobacter | 12 |
HAPE | 12 |
Haemophilus | 12 |
HMGB1 | 12 |
HHT | 12 |
Glucocorticoids | 12 |
GLI | 12 |
GG | 12 |
Für | 12 |
LTE | 12 |
Fällen | 12 |
Ireland | 12 |
Mesothelin | 12 |
Laboratory | 12 |
Levy | 12 |
PP | 12 |
FFM | 12 |
PIP | 12 |
PEG | 12 |
Objectives | 12 |
Novel | 12 |
Novartis | 12 |
Non | 12 |
NL63 | 12 |
NIPPV | 12 |
Medikamente | 12 |
Mediatoren | 12 |
Med | 12 |
Mastzellen | 12 |
Madrid | 12 |
MMP | 12 |
MBNW | 12 |
Family | 12 |
Bestimmung | 12 |
FAS | 12 |
Boston | 12 |
BDI | 12 |
Auckland | 12 |
Atopie | 12 |
Asthmakontrolle | 12 |
Americans | 12 |
Als | 12 |
Alpha-1 | 12 |
Ageing | 12 |
ATP | 12 |
ARQL | 12 |
AQLQ | 12 |
AP-1 | 12 |
AIHW | 12 |
A549 | 12 |
A1 | 12 |
6MWD | 12 |
Pearson | 12 |
BP14 | 12 |
CNPA | 12 |
Expert | 12 |
CRE | 12 |
Einsatz | 12 |
Eigenschaften | 12 |
EP2 | 12 |
EEG | 12 |
Dp | 12 |
Die | 12 |
Dermatitis | 12 |
Denmark | 12 |
Database | 12 |
DMARD | 12 |
Cysteinyl | 12 |
Crohn | 12 |
Costa | 12 |
Chlamydophila | 12 |
Cell | 12 |
CXR | 12 |
CREB | 12 |
Pathogenesis | 12 |
NIV | 12 |
Peking | 12 |
explicação | 12 |
importante | 12 |
immer | 12 |
hyperreactivity | 12 |
hypercapnic | 12 |
hier | 12 |
grau | 12 |
findet | 12 |
fenótipos | 12 |
eotaxin-3 | 12 |
deshalb | 12 |
eotaxin-2 | 12 |
eotaxin-1 | 12 |
entzündungsauflösenden | 12 |
entre | 12 |
dürfte | 12 |
doenças | 12 |
disease | 12 |
diesen | 12 |
infecção | 12 |
kommen | 12 |
lassen | 12 |
maior | 12 |
Pitjantjatjara | 12 |
vias | 12 |
tipo | 12 |
tiotropium | 12 |
thoracoscopy | 12 |
ter | 12 |
também | 12 |
spray | 12 |
seu | 12 |
rst | 12 |
receptores | 12 |
prednisolone | 12 |
porque | 12 |
perfil | 12 |
muito | 12 |
muitas | 12 |
mcg | 12 |
deste | 12 |
sodass | 12 |
desenvolvimento | 12 |
Säuglingen | 12 |
Stunden | 12 |
Strasbourg | 12 |
Strait | 12 |
St. | 12 |
Southern | 12 |
Score | 12 |
SLS | 12 |
S3 | 12 |
S1 | 12 |
Pneumocystis | 12 |
weitere | 12 |
Roflumilast | 12 |
Rhinoviruses | 12 |
RI | 12 |
RHC | 12 |
Que | 12 |
dar | 12 |
Symptomatik | 12 |
Regional | 12 |
TAHS | 12 |
agressões | 12 |
beobachtete | 12 |
Tasmania | 12 |
beobachtet | 12 |
aéreas | 12 |
através | 12 |
artPAH | 12 |
animais | 12 |
albuterol | 12 |
benralizumab | 12 |
aGVHD | 12 |
Veränderungen | 12 |
Zytokine | 12 |
X | 12 |
VZV | 12 |
Wilcoxon | 12 |
W. | 12 |
a3 | 12 |
IPI | 11 |
IMMUNOLOGY | 11 |
IB | 11 |
Homöostase | 11 |
HRF | 11 |
HPLC | 11 |
HIF-1α | 11 |
HPF | 11 |
HPA | 11 |
Genome | 11 |
GSK | 11 |
Feno | 11 |
Johnson | 11 |
Expression | 11 |
ISU | 11 |
Matrix | 11 |
Konzentrationen | 11 |
LTA | 11 |
LTRA | 11 |
Lipopolysaccharide | 11 |
Louisiana | 11 |
Lunge | 11 |
MZ | 11 |
Maresine | 11 |
Maßnahmen | 11 |
Meta | 11 |
Model | 11 |
N. | 11 |
nan | 11 |
NFATc1 | 11 |
EU | 11 |
Environment | 11 |
BEC | 11 |
ET-1 | 11 |
AU | 11 |
Ann | 11 |
Alter | 11 |
Allergologie | 11 |
Allergie | 11 |
Adenovirus | 11 |
Acinetobacter | 11 |
ASTHMA | 11 |
ERK | 11 |
AMP | 11 |
AIDS | 11 |
ADRB2 | 11 |
ACE | 11 |
-7 | 11 |
Nachweis | 11 |
BM32 | 11 |
Baseline | 11 |
Beschwerden | 11 |
Beurteilung | 11 |
Board | 11 |
Bocavirus | 11 |
CH50 | 11 |
CMPA | 11 |
Canadian | 11 |
Centers | 11 |
Child | 11 |
Consensus | 11 |
DMEM | 11 |
Daten | 11 |
Diagnostic | 11 |
Diet | 11 |
EP2-Rezeptoren | 11 |
NTM | 11 |
NS | 11 |
Nasal | 11 |
finden | 11 |
letzten | 11 |
lcFOS | 11 |
ketotifen | 11 |
kUA | 11 |
inflammatorischen | 11 |
ihre | 11 |
erhöhen | 11 |
administration | 11 |
eosinophilia | 11 |
eosinophilen | 11 |
eher | 11 |
damit | 11 |
chronischen | 11 |
atópico | 11 |
lymphopenia | 11 |
min | 11 |
möglich | 11 |
n-3-PUFAs | 11 |
oben | 11 |
rBet | 11 |
rhinosinusitis | 11 |
scan | 11 |
selten | 11 |
sido | 11 |
sintomas | 11 |
somit | 11 |
tumstatin | 11 |
weil | 11 |
wirkt | 11 |
zanamivir | 11 |
Nrf2 | 11 |
asmático | 11 |
neutrophile | 11 |
Wie | 11 |
Rapid | 11 |
Short | 11 |
Sekretion | 11 |
SAS | 11 |
SAFS | 11 |
Risikofaktoren | 11 |
Regel | 11 |
Public | 11 |
Specific | 11 |
Primary | 11 |
Pneumonia | 11 |
Panel | 11 |
PIV-1 | 11 |
Werte | 11 |
PGD2 | 11 |
Smith | 11 |
RCTs | 11 |
Stachybotrys | 11 |
Tregs | 11 |
WU | 11 |
Symptomen | 11 |
WBC | 11 |
Vermehrung | 11 |
U.K. | 11 |
U. | 11 |
VIW | 11 |
TX | 11 |
TMP | 11 |
TARC | 11 |
Säuglinge | 11 |
Synthese | 11 |
11 | |
Neben | 10 |
Leukotrienen | 10 |
Na | 10 |
NV | 10 |
NIP45 | 10 |
Munich | 10 |
ODN | 10 |
Mouse | 10 |
MON | 10 |
M2-Makrophagen | 10 |
Infekte | 10 |
Latin | 10 |
Körper | 10 |
KI | 10 |
Inhalation | 10 |
IVIg | 10 |
IS | 10 |
IL5 | 10 |
OM-85 | 10 |
IL4 | 10 |
OM | 10 |
RA | 10 |
Obstructive | 10 |
Protektine | 10 |
Homeopathy | 10 |
Schwangerschaft | 10 |
SU | 10 |
SMX | 10 |
Russia | 10 |
RIS | 10 |
QD | 10 |
Q | 10 |
Pneumonie | 10 |
Oscillometry | 10 |
Plasma | 10 |
Periostin | 10 |
Pediatr | 10 |
PTGDR | 10 |
PSG | 10 |
PF | 10 |
PDGFRA | 10 |
PDE4 | 10 |
Hyperreaktivität | 10 |
Blo | 10 |
Helsinki | 10 |
CCL17 | 10 |
Delta | 10 |
DM | 10 |
DLQI | 10 |
Cross | 10 |
CoV | 10 |
Cells | 10 |
Candida | 10 |
CD63 | 10 |
BNP | 10 |
EC | 10 |
BDR | 10 |
Se | 10 |
AzeFlu | 10 |
Außerdem | 10 |
Anzahl | 10 |
Aktivität | 10 |
Abstract | 10 |
ARC | 10 |
District | 10 |
EEC | 10 |
Haut | 10 |
Ghent | 10 |
HS | 10 |
HRQL | 10 |
HKU1 | 10 |
HCoV-229E | 10 |
HCWs | 10 |
HCW | 10 |
Gly | 10 |
Giemen | 10 |
Genetics | 10 |
EEU | 10 |
GST | 10 |
GEE | 10 |
Fibrose | 10 |
Factor | 10 |
Equine | 10 |
Episoden | 10 |
Effekte | 10 |
EG2 | 10 |
Science | 10 |
sinnvoll | 10 |
Services | 10 |
longo | 10 |
parvalbumin | 10 |
p2 | 10 |
novos | 10 |
nonallergic | 10 |
modulação | 10 |
microbiana | 10 |
methylprednisolone | 10 |
metalloproteinase-9 | 10 |
leukotriene | 10 |
precoce | 10 |
infância | 10 |
inata | 10 |
idade | 10 |
i.p | 10 |
i.n | 10 |
hoje | 10 |
hohen | 10 |
hipótese | 10 |
peak | 10 |
presença | 10 |
frequência | 10 |
secreção | 10 |
Sick | 10 |
wenig | 10 |
wall | 10 |
tempos | 10 |
sua | 10 |
spirometric | 10 |
sobretudo | 10 |
selbst | 10 |
sec | 10 |
primeiro | 10 |
sICAM-1 | 10 |
s.c | 10 |
roe | 10 |
pulmonale | 10 |
protein | 10 |
progranulin | 10 |
produtos | 10 |
processo | 10 |
higiénica | 10 |
poderá | 10 |
fluticasone | 10 |
alergénios | 10 |
agentes | 10 |
actuação | 10 |
Zytokinen | 10 |
XLA | 10 |
Wu | 10 |
WDEIA | 10 |
Viren | 10 |
Verlauf | 10 |
VSMC | 10 |
Untersuchung | 10 |
Trial | 10 |
Transbronchial | 10 |
Tiotropium | 10 |
Th2-Zellen | 10 |
TIMP | 10 |
Säuglingsalter | 10 |
Surveillance | 10 |
faz | 10 |
Streptococcus | 10 |
ainda | 10 |
Victoria | 10 |
exacerbações | 10 |
denen | 10 |
expressão | 10 |
ambiente | 10 |
estudo | 10 |
erst | 10 |
epidemiológicos | 10 |
epi | 10 |
elevada | 10 |
doc_id | 10 |
eosinophil | 10 |
consequências | 10 |
bildet | 10 |
antigen | 10 |
campo | 10 |
bekannt | 10 |
asmáticos | 10 |
bp | 10 |
bpm | 10 |
HBV | 9 |
F. | 9 |
H5N1 | 9 |
H-1A | 9 |
Gesunden | 9 |
HCA | 9 |
George | 9 |
Figure | 9 |
Ficoll | 9 |
Fettsäuren | 9 |
Dr | 9 |
Exhaled | 9 |
Ethics | 9 |
Escherichia | 9 |
Entstehung | 9 |
Early | 9 |
ESR | 9 |
EIB | 9 |
Dyspnea | 9 |
HMWK | 9 |
HI | 9 |
Obstruktion | 9 |
HR | 9 |
Hyperreagibilität | 9 |
DZ | 9 |
Obwohl | 9 |
Nebenwirkungen | 9 |
NSAIDs | 9 |
NFA | 9 |
NAR | 9 |
Mini | 9 |
Metapneumovirus | 9 |
Malaga | 9 |
MNC | 9 |
Lungenfunktion | 9 |
Leukotrien | 9 |
LEV | 9 |
John | 9 |
Institutional | 9 |
Inflammatory | 9 |
Infectious | 9 |
Immunantworten | 9 |
IL18 | 9 |
Detection | 9 |
AI | 9 |
DSM | 9 |
Betaseron | 9 |
Australians | 9 |
Atemwegsobstruktion | 9 |
AstraZeneca | 9 |
Area | 9 |
Allergene | 9 |
Agency | 9 |
Aerocrine | 9 |
Administration | 9 |
Adelaide | 9 |
Acute | 9 |
AVM | 9 |
APC | 9 |
AMC | 9 |
ALI | 9 |
ALA | 9 |
AJ | 9 |
OrnOrnGlu(C | 9 |
ADA | 9 |
7S | 9 |
BMT | 9 |
C3 | 9 |
DLCO | 9 |
C60 | 9 |
DEXA | 9 |
DDA | 9 |
D4 | 9 |
D3 | 9 |
D2 | 9 |
County | 9 |
Compositae | 9 |
ClinicalTrials.gov | 9 |
Clearance | 9 |
Chest | 9 |
Chemotaxis | 9 |
Cav | 9 |
CD86 | 9 |
CD203c | 9 |
CD11c | 9 |
CCL7 | 9 |
CBF | 9 |
CBC | 9 |
CAC | 9 |
Olivenöl | 9 |
Energy | 9 |
P<.01 | 9 |
i.v | 9 |
hemmen | 9 |
genética | 9 |
gegen | 9 |
etwa | 9 |
erhöhte | 9 |
enteroviruses | 9 |
el | 9 |
einzelnen | 9 |
effi | 9 |
dürften | 9 |
dupilumab | 9 |
corticosteroid | 9 |
chronisch | 9 |
ca | 9 |
bronchialen | 9 |
bewirkt | 9 |
beschrieben | 9 |
allergica | 9 |
aktiviert | 9 |
häufig | 9 |
interleukin-8 | 9 |
Zusammenhang | 9 |
mL. | 9 |
P=.001 | 9 |
≥3 | 9 |
≤ | 9 |
¼ | 9 |
zileuton | 9 |
un | 9 |
terfenadine | 9 |
tachypnea | 9 |
rasch | 9 |
propionate | 9 |
proinflammatorischen | 9 |
primär | 9 |
pred | 9 |
pneumococcus | 9 |
oxaliplatin | 9 |
oseltamivir | 9 |
ob | 9 |
nut | 9 |
neue | 9 |
_ | 9 |
vedolizumab | 9 |
Zu | 9 |
SM | 9 |
Republic | 9 |
Remodeling | 9 |
Raw | 9 |
RTI | 9 |
RME | 9 |
RFLP | 9 |
Qiagen | 9 |
PubMed | 9 |
Prospective | 9 |
Produktion | 9 |
Predictors | 9 |
Phänotypen | 9 |
Peter | 9 |
Pathway | 9 |
PST | 9 |
POBA | 9 |
PIAMA | 9 |
Yang | 9 |
PGE | 9 |
Resveratrol | 9 |
PIV-3 | 9 |
SNIPPV | 9 |
Univariate | 9 |
Serhan | 9 |
Working | 9 |
Wheezing | 9 |
Welfare | 9 |
WCC | 9 |
WA | 9 |
Ves | 9 |
V. | 9 |
Wirkungen | 9 |
Tumor | 9 |
TEWL | 9 |
Stage | 9 |
Therapy | 9 |
Strategy | 9 |
TENOR | 9 |
Wong | 9 |
Thailand | 9 |
TH | 9 |
TGFb | 9 |
Mch | 8 |
Jugendlichen | 8 |
Kaplan | 8 |
Kco | 8 |
Keywords | 8 |
Kontakt | 8 |
Kruskal | 8 |
LEN | 8 |
LP | 8 |
La | 8 |
Lands | 8 |
Li | 8 |
Lipoxinen | 8 |
Lys | 8 |
M2a | 8 |
MSP-1(42 | 8 |
Massachusetts | 8 |
Jahr | 8 |
Low | 8 |
Hobart | 8 |
Jaakkola | 8 |
Islanders | 8 |
Government | 8 |
Mus | 8 |
Gp | 8 |
Gp130 | 8 |
Grs | 8 |
H3N2 | 8 |
HA | 8 |
HCoVs | 8 |
HRSV | 8 |
Hg | 8 |
Hier | 8 |
IGF | 8 |
IL-1a | 8 |
INTRODUCTION | 8 |
Incidence | 8 |
Indikation | 8 |
Intervention | 8 |
Mortality | 8 |
PPE | 8 |
NKT | 8 |
NL | 8 |
PUFA | 8 |
PaCO2 | 8 |
Pandemic | 8 |
Parainfluenza | 8 |
Parameter | 8 |
Paramyxoviridae | 8 |
Pattern | 8 |
Peach | 8 |
Pharmacia | 8 |
Pk | 8 |
Pl | 8 |
Plan | 8 |
Poland | 8 |
Pplat | 8 |
Prozesse | 8 |
QoL | 8 |
GBM | 8 |
PSD | 8 |
PPEC | 8 |
POF | 8 |
OME | 8 |
NOD | 8 |
NRE | 8 |
Nestle | 8 |
Neutrophilic | 8 |
Nil | 8 |
Nomination | 8 |
Norris | 8 |
OSM | 8 |
PICU | 8 |
Occupational | 8 |
Office | 8 |
Oral | 8 |
P1 | 8 |
PBA | 8 |
PEFR | 8 |
PET | 8 |
GlaxoSmithKline | 8 |
CCL2 | 8 |
Fähigkeit | 8 |
Alzheimer | 8 |
Antigene | 8 |
Antwort | 8 |
Art | 8 |
Asthmaanfall | 8 |
Atemwegsepithel | 8 |
BMP2 | 8 |
Bachert | 8 |
Bacterial | 8 |
Belgium | 8 |
Benefits | 8 |
Biopsy | 8 |
Biosynthese | 8 |
Borg | 8 |
Braun | 8 |
Bronchial | 8 |
Bronchien | 8 |
CCL20 | 8 |
Amb | 8 |
Alveolitis | 8 |
FOL | 8 |
Alexithymia | 8 |
R5 | 8 |
-/-;IL-11aR | 8 |
105AA | 8 |
114CC | 8 |
3C | 8 |
757F | 8 |
AAI | 8 |
ABG | 8 |
ACQLQ | 8 |
ACh | 8 |
AECOPD | 8 |
AIN | 8 |
ALK | 8 |
ALX | 8 |
AOR | 8 |
Abgrenzung | 8 |
Activity | 8 |
CD40 | 8 |
CD56 | 8 |
CMP | 8 |
CO2 | 8 |
DRSXrs | 8 |
DSTAT | 8 |
DX-88 | 8 |
Dauer | 8 |
Definition | 8 |
Dexamethason | 8 |
Differenzierung | 8 |
Division | 8 |
DoHA | 8 |
EAR | 8 |
EPT | 8 |
Effectiveness | 8 |
Einfluss | 8 |
Em | 8 |
Erwägung | 8 |
F508del | 8 |
FBS | 8 |
DRSGrs | 8 |
DOT | 8 |
DLco | 8 |
Carlos | 8 |
COX-1 | 8 |
CS | 8 |
CSMS | 8 |
CXCL10 | 8 |
Ca | 8 |
Cairns | 8 |
Campylobacter | 8 |
Caucasians | 8 |
Critical | 8 |
Chan | 8 |
Characteristics | 8 |
Chinese | 8 |
Clara | 8 |
CoQ10 | 8 |
Copaxone | 8 |
Corticosteroid | 8 |
R129160 | 8 |
Paque | 8 |
RAO | 8 |
leflunomide | 8 |
macrófagos | 8 |
mass | 8 |
meisten | 8 |
menor | 8 |
metformin | 8 |
modelos | 8 |
molecule-1 | 8 |
multiparameter | 8 |
n-3-Fettsäuren | 8 |
neste | 8 |
neutrofílica | 8 |
neutrófilos | 8 |
ng/ | 8 |
nsLTPs | 8 |
numa | 8 |
obliterans | 8 |
obstruktive | 8 |
lysates | 8 |
lactoglobulin | 8 |
palivizumab | 8 |
kcal | 8 |
formas | 8 |
frühen | 8 |
gefi | 8 |
goat | 8 |
gp130 | 8 |
granulysin | 8 |
h2 | 8 |
heute | 8 |
homozigotia | 8 |
hypopnoea | 8 |
há | 8 |
identifi | 8 |
inflamatórias | 8 |
influência | 8 |
interferon | 8 |
interleukin-6 | 8 |
investigação | 8 |
ovalbumin | 8 |
pcg | 8 |
exprimiert | 8 |
suas | 8 |
só | 8 |
tal | 8 |
teno | 8 |
teoria | 8 |
tinib | 8 |
todos | 8 |
tropomyosin | 8 |
tão | 8 |
vem | 8 |
vermehrte | 8 |
verstärkt | 8 |
verwendet | 8 |
vão | 8 |
welche | 8 |
zugrunde | 8 |
zymography | 8 |
RE | 8 |
síntese | 8 |
stellt | 8 |
pemetrexed | 8 |
sinonasal | 8 |
pemphigus | 8 |
plasmacytoid | 8 |
pneumovirus | 8 |
podem | 8 |
polimorfismos | 8 |
possa | 8 |
produção | 8 |
receptor | 8 |
relação | 8 |
restenosis | 8 |
scFOS | 8 |
scheinen | 8 |
schwer | 8 |
schwerer | 8 |
scid | 8 |
sem | 8 |
sh | 8 |
foi | 8 |
vasculopathy | 8 |
evolução | 8 |
Será | 8 |
Standards | 8 |
Streptococus | 8 |
Summary | 8 |
TBK | 8 |
TGFßinduced | 8 |
TGV | 8 |
TH1 | 8 |
TMPRSS2 | 8 |
TTE | 8 |
Target | 8 |
Tasmanian | 8 |
Taxus | 8 |
Team | 8 |
Tennessee | 8 |
Tezepelumab | 8 |
Th2-type | 8 |
Thrombin | 8 |
Squared | 8 |
Section | 8 |
Uma | 8 |
Secretory | 8 |
está | 8 |
RV16 | 8 |
Randomized | 8 |
Rat | 8 |
Raynaud | 8 |
Rica | 8 |
Romagnani | 8 |
Rrs | 8 |
SCID | 8 |
SFA | 8 |
SSPTX | 8 |
ST2 | 8 |
STAT3 | 8 |
© | 8 |
Salsola | 8 |
Scheme | 8 |
Schols | 8 |
Total | 8 |
Respir | 8 |
VSD | 8 |
bem | 8 |
blockieren | 8 |
bortezomib | 8 |
brimonidine | 8 |
capacidade | 8 |
clavulanic | 8 |
clínica | 8 |
confi | 8 |
densitometry | 8 |
destes | 8 |
diminuição | 8 |
direkt | 8 |
dois | 8 |
défice | 8 |
eosinophile | 8 |
epitélio | 8 |
Vanderbilt | 8 |
específica | 8 |
beteiligt | 8 |
entzündliche | 8 |
bacterianos | 8 |
além | 8 |
autoimunes | 8 |
Vorliegen | 8 |
Victorian | 8 |
White | 8 |
Verbesserung | 8 |
Zhang | 8 |
Zusätzlich | 8 |
aeroallergen | 8 |
WMD | 8 |
anderer | 8 |
angiosarcoma | 8 |
antivirusal | 8 |
aorto | 8 |
apple | 8 |
analysis | 8 |
até | 8 |
KD | 7 |
ISS | 7 |
Hirst | 7 |
Hodgkin | 7 |
Hyposensibilisierung | 7 |
IL-15 | 7 |
IRF7 | 7 |
Interview | 7 |
Imaging | 7 |
Inc | 7 |
Induced | 7 |
Intubation | 7 |
Investigation | 7 |
Israel | 7 |
Je | 7 |
Hemmer | 7 |
Green | 7 |
Havemeyer | 7 |
Genes | 7 |
FI | 7 |
FN | 7 |
Komponente | 7 |
Familie | 7 |
Formoterol | 7 |
GPIAG | 7 |
Geburt | 7 |
Gesellschaft | 7 |
HVAC | 7 |
Gln | 7 |
Grad | 7 |
Growth | 7 |
H1 | 7 |
HDAC | 7 |
HIV-1 | 7 |
HPIC | 7 |
Kindesalter | 7 |
NAA | 7 |
Kosten | 7 |
LDR | 7 |
NSA | 7 |
Norway | 7 |
Objective | 7 |
Outcomes | 7 |
P2 | 7 |
P3 | 7 |
PATHWAY | 7 |
PCLS | 7 |
PCP | 7 |
PKC | 7 |
Pathogen | 7 |
Phagozytose | 7 |
Philadelphia | 7 |
Endotoxin | 7 |
Phleum | 7 |
NLR | 7 |
NHLBI | 7 |
NCFB | 7 |
MHES | 7 |
LSA | 7 |
Linolensäure | 7 |
Liu | 7 |
LoS | 7 |
Longitudinal | 7 |
Loss | 7 |
MRA | 7 |
Monozyten | 7 |
MVOCs | 7 |
Man | 7 |
Manchester | 7 |
Mengen | 7 |
Molecular | 7 |
Mometasone | 7 |
Ex | 7 |
CEP | 7 |
Endothelzellen | 7 |
CPT | 7 |
B12 | 7 |
BY | 7 |
Bakterien | 7 |
Behcet | 7 |
Belastung | 7 |
Berlin | 7 |
Bethesda | 7 |
Biomarkers | 7 |
Bla | 7 |
Body | 7 |
Boehringer | 7 |
Bone | 7 |
Bronchopulmonary | 7 |
CCD | 7 |
CCR4 | 7 |
Austria | 7 |
Auslöser | 7 |
Auftreten | 7 |
Allergens | 7 |
Pleural | 7 |
ACOCU | 7 |
AH | 7 |
ALYATEC | 7 |
ARG1 | 7 |
Akt | 7 |
Allergology | 7 |
Atmung | 7 |
Anamnese | 7 |
Anstrengungsasthma | 7 |
Antigen | 7 |
Arg | 7 |
Asthmas | 7 |
Atemnot | 7 |
COAST | 7 |
CRScNP | 7 |
Empfehlungen | 7 |
CRSsNP | 7 |
Danish | 7 |
Darüber | 7 |
David | 7 |
Declaration | 7 |
Dennis | 7 |
Design | 7 |
Di | 7 |
Difficult | 7 |
Digital | 7 |
Dx | 7 |
ECP434G | 7 |
EGF | 7 |
Eastern | 7 |
Eicosanoid | 7 |
Einteilung | 7 |
Danazol | 7 |
Daily | 7 |
Da | 7 |
Comparison | 7 |
CSS | 7 |
CTGF | 7 |
Calu-3 | 7 |
Castro | 7 |
Chap | 7 |
Chicago | 7 |
Compilation | 7 |
DR+ | 7 |
Cor | 7 |
Craig | 7 |
Creative | 7 |
Crud | 7 |
DD | 7 |
DGS | 7 |
Pla | 7 |
LTD | 7 |
Prednisone | 7 |
intranasal | 7 |
itraconazole | 7 |
iv | 7 |
jungen | 7 |
klinisch | 7 |
lansoprazole | 7 |
liegt | 7 |
los | 7 |
lymphopoietin | 7 |
mHealth | 7 |
max | 7 |
mitogens | 7 |
mmol | 7 |
möglichst | 7 |
müssen | 7 |
nM | 7 |
ipratropium | 7 |
insbesondere | 7 |
entstehen | 7 |
infliximab | 7 |
erklärt | 7 |
esta | 7 |
express | 7 |
ganz | 7 |
gehören | 7 |
gezeigt | 7 |
gezogen | 7 |
h. | 7 |
hRSV | 7 |
handelt | 7 |
hazel | 7 |
hilfreich | 7 |
hin | 7 |
i | 7 |
immunologische | 7 |
ned | 7 |
nedocromil | 7 |
oberen | 7 |
pAra | 7 |
vermeiden | 7 |
vermittelt | 7 |
vermutlich | 7 |
wissenschaftliche | 7 |
wurden | 7 |
zeigte | 7 |
zeigten | 7 |
zunächst | 7 |
zusätzlich | 7 |
À | 7 |
× | 7 |
Über | 7 |
β1 | 7 |
≥2 | 7 |
Presence | 7 |
unspezifische | 7 |
tropicalis | 7 |
tolerogenic | 7 |
refl | 7 |
pimecrolimus | 7 |
pneumocystis | 7 |
pulmonalen | 7 |
rCari | 7 |
rDer | 7 |
rRNA | 7 |
resolvin | 7 |
todas | 7 |
rhinovirus | 7 |
spielt | 7 |
später | 7 |
stehen | 7 |
steht | 7 |
telithromycin | 7 |
erhöhten | 7 |
tritt | 7 |
dL | 7 |
Thrombozyten | 7 |
Smad | 7 |
Spanish | 7 |
Stata | 7 |
Status | 7 |
Substanzen | 7 |
Switzerland | 7 |
São | 7 |
TAI | 7 |
TBM | 7 |
TCR | 7 |
TCRI | 7 |